DK0854874T3 - Makrocykliske lactonforbindelser og fremgangsmåde til fremstilling af disse - Google Patents

Makrocykliske lactonforbindelser og fremgangsmåde til fremstilling af disse

Info

Publication number
DK0854874T3
DK0854874T3 DK95932876T DK95932876T DK0854874T3 DK 0854874 T3 DK0854874 T3 DK 0854874T3 DK 95932876 T DK95932876 T DK 95932876T DK 95932876 T DK95932876 T DK 95932876T DK 0854874 T3 DK0854874 T3 DK 0854874T3
Authority
DK
Denmark
Prior art keywords
macrocyclic lactone
processes
preparation
lactone compounds
compound
Prior art date
Application number
DK95932876T
Other languages
Danish (da)
English (en)
Inventor
Pharm Inc Nagoya Plan H-Pfizer
Phar Inc Nagoyaplant Y-Pfizer
Phar Inc Nagoya Plant T-Pfizer
Phar Inc Nagoya Plant Y-Pfizer
Pharm Inc Nagoya Plan N-Pfizer
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of DK0854874T3 publication Critical patent/DK0854874T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/188—Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyrane Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Saccharide Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK95932876T 1994-11-10 1995-10-13 Makrocykliske lactonforbindelser og fremgangsmåde til fremstilling af disse DK0854874T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP9401896 1994-11-10
PCT/IB1995/000870 WO1996015131A1 (en) 1994-11-10 1995-10-13 Macrocyclic lactone compounds and their production process

Publications (1)

Publication Number Publication Date
DK0854874T3 true DK0854874T3 (da) 2003-06-02

Family

ID=1341416

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95932876T DK0854874T3 (da) 1994-11-10 1995-10-13 Makrocykliske lactonforbindelser og fremgangsmåde til fremstilling af disse

Country Status (12)

Country Link
US (2) US6001998A (fi)
EP (1) EP0854874B1 (fi)
JP (1) JP3061863B2 (fi)
AT (1) ATE239024T1 (fi)
CA (1) CA2204739C (fi)
DE (1) DE69530616T2 (fi)
DK (1) DK0854874T3 (fi)
ES (1) ES2194054T3 (fi)
FI (1) FI971995A (fi)
MX (1) MX9703484A (fi)
PT (1) PT854874E (fi)
WO (1) WO1996015131A1 (fi)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT854874E (pt) * 1994-11-10 2003-07-31 Pfizer Compostos de lactona macrociclica e seu processo de producao
US20040235889A1 (en) * 2001-05-02 2004-11-25 Miao-Kun Sun Carbonic anhydrase activator for enhancing learning and memory
US6551591B1 (en) 2001-09-07 2003-04-22 Essential Therapeutics, Inc. Antibiotics from microbispora
US6825229B2 (en) 2002-03-07 2004-11-30 Blanchette Rockefeller Neurosciences Institute Methods for Alzheimer's Disease treatment and cognitive enhancement
US20080004332A1 (en) * 2002-03-07 2008-01-03 Alkon Daniel L Methods for alzheimer's disease treatment and cognitive enhancement
US20050065205A1 (en) * 2002-03-07 2005-03-24 Daniel Alkon Methods for Alzheimer's disease treatment and cognitive enhance
US7709632B2 (en) * 2004-02-17 2010-05-04 Johnson Thomas E Methods, compositions, and apparatuses for forming macrocyclic compounds
TW200538181A (en) * 2004-05-18 2005-12-01 Brni Neurosciences Inst Treatment of depressive disorders
EP1768662A2 (en) 2004-06-24 2007-04-04 Novartis Vaccines and Diagnostics, Inc. Small molecule immunopotentiators and assays for their detection
CA2598805A1 (en) * 2005-02-24 2006-08-31 Biocern, Inc. Sperm cell separation methods and compositions
WO2006119211A2 (en) * 2005-05-02 2006-11-09 Genaera Corporation Methods and compositions for treating ocular disorders
WO2007016202A1 (en) 2005-07-29 2007-02-08 Blanchette Rockefeller Neurosciences Institute Use of a pkc activator, alone or combined with a pkc inhibitor to enhance long term memory
CA2659242C (en) 2006-07-28 2015-08-11 Blanchette Rockefeller Neurosciences Institute Methods of stimulating cellular growth, synaptic remodeling and consolidation of long-term memory
NZ575829A (en) * 2006-08-30 2012-04-27 Biocern Inc Sperm cell separation methods and compositions containing aptamers or nucleic acid sequences for use therein
EP2702993B1 (en) * 2006-09-13 2017-12-06 Elixir Medical Corporation Macrocyclic lactone compounds and methods for their use
US8088789B2 (en) 2006-09-13 2012-01-03 Elixir Medical Corporation Macrocyclic lactone compounds and methods for their use
US10695327B2 (en) 2006-09-13 2020-06-30 Elixir Medical Corporation Macrocyclic lactone compounds and methods for their use
CA2873179A1 (en) 2007-02-09 2008-08-21 Blanchette Rockefeller Neurosciences Institute Use of bryostatins and neristatins in the treatment of cognitive impairment due to head trauma
CA2864550C (en) 2007-02-09 2018-07-10 Blanchette Rockefeller Neurosciences Institute Therapeutic effects of bryostatins, bryologs, and other related substances on ischemia/stroke-induced memory impairment and brain injury
JP5726171B2 (ja) * 2009-05-01 2015-05-27 グリコミメティックス インコーポレイテッド Ｅ−セレクチンおよびｃｘｃｒ４ケモカイン受容体のヘテロ二官能性阻害剤
EP3141246A1 (en) * 2009-08-31 2017-03-15 Dr. Reddy's Laboratories Ltd. Topical formulations comprising a steroid
WO2012006516A2 (en) 2010-07-08 2012-01-12 Alkon Daniel L Dag-type and indirect protein kinase c activators and anticoagulant for the treatment of stroke
JP6062362B2 (ja) 2010-08-19 2017-01-18 ブランシェット・ロックフェラー・ニューロサイエンスィズ・インスティテュート Ｐｋｃ活性化剤を使用した、異常な樹状突起棘に関連した認知障害の治療
JP6422778B2 (ja) 2011-11-13 2018-11-14 ブランシェット・ロックフェラー・ニューロサイエンスィズ・インスティテュート Ｐｋｃアクチベーターおよびその組合せ
CA2985625A1 (en) 2015-05-11 2016-11-17 Alkon, Daniel L. Treatment of neurodegenerative conditions using pkc activators after determining the presence of the apoe4 allele
RU2629653C1 (ru) * 2016-03-21 2017-08-30 Федеральное государственное бюджетное образовательное учреждение высшего образования "Юго-Западный государственный университет " (ЮЗГУ) Мостовой измеритель параметров двухполюсников
CN107827803A (zh) * 2017-11-28 2018-03-23 绍兴厚普生物科技有限责任公司 一种从发酵液中提取l‑羟脯氨酸的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6903238A (fi) * 1968-03-04 1969-09-08
US5091389A (en) * 1991-04-23 1992-02-25 Merck & Co., Inc. Lipophilic macrolide useful as an immunosuppressant
US5674732A (en) * 1992-04-27 1997-10-07 Pfizer Inc. Rapamycin producer
CA2106034A1 (en) * 1992-09-24 1994-03-25 Ralph J. Russo 21-norrapamycin
PT854874E (pt) * 1994-11-10 2003-07-31 Pfizer Compostos de lactona macrociclica e seu processo de producao

Also Published As

Publication number Publication date
EP0854874A1 (en) 1998-07-29
MX9703484A (es) 1997-08-30
JPH11507907A (ja) 1999-07-13
JP3061863B2 (ja) 2000-07-10
PT854874E (pt) 2003-07-31
ES2194054T3 (es) 2003-11-16
DE69530616T2 (de) 2004-04-01
FI971995A0 (fi) 1997-05-09
FI971995A (fi) 1997-05-09
ATE239024T1 (de) 2003-05-15
EP0854874B1 (en) 2003-05-02
DE69530616D1 (de) 2003-06-05
US6001998A (en) 1999-12-14
WO1996015131A1 (en) 1996-05-23
CA2204739C (en) 2000-04-04
US6187568B1 (en) 2001-02-13

Similar Documents

Publication Publication Date Title
DK0854874T3 (da) Makrocykliske lactonforbindelser og fremgangsmåde til fremstilling af disse
MY140677A (en) Modified amino acids, pharmaceuticals containing these compounds and method for their production
MXPA02004415A (es) Pirazolonas sustituidas con heterociclicas.
RU94042903A (ru) 3,4,4-трехзамещенные пиперидинил-n-алкилкарбоксилаты и промежуточные соединения, способ их получения, фармкомпозиция
GR3030342T3 (en) Cyclobutane derivatives as inhibitors of squalene synthetase and protein farnesyltransferase.
BG100951A (en) Novel erythromycin derivatives, method for their preparation and their use as drugs
MX9707706A (es) Compuestos intermediarios novedosos y proceso para la manufactura de derivados de la camptotecina (cpt-11) y compuestos relacionados.
EA199901016A1 (ru) 9-оксим-производные эритромицина
ATE475653T1 (de) Verfahren zur herstellung von valsartan
ZA979553B (en) Bacterial strains and use thereof in fermentation processes for 2-keto-L-gulonic acid production.
MY145819A (en) Process and intermediates useful in the preparation of pharmaceutical compounds as fulvestrant
NO974320L (no) Fucopeptider
AU1306795A (en) Anticonvulsant pseudofructopyranose sulfamates
DE60235365D1 (de) Verfahren zur herstellung von 7-amino-syn-3,5-dihydroxyheptansäurederivaten und zwischenverbindungen diesesverfahrens und deren herestellung
CA2019799A1 (en) Fucosidase inhibitor
DE3672361D1 (de) Ein neues ansamycin-antibiotikum, ein mikrobielles verfahren zu seiner herstellung und seine verwendung als arzneimittel.
AU6820096A (en) Selective process for the deacylation of acylated compounds
DK0852232T3 (da) Cykliske peptidforbindelser til behandling af smerte og deres fremstillingsproces
BG103704A (en) New compounds
DK0638125T3 (da) Actinoplaner til produktion af rapamycin
ATE8133T1 (de) Neues peptid-antibiotikum komponente a, verfahren zu seiner herstellung sowie seine verwendung in arzneimitteln.
JO1945B1 (en) A bioactive active substance and a way to prepare and use it
CA2230303A1 (en) Polymorphs of the prodrug 6-n-(l-ala-l-ala)-trovafloxacin
KR960037685A (ko) 암모니오세팔로스포린 계열 항생제 및 그의 제조방법
NZ329604A (en) Isoxazole derivatives substituted by an amino, guanidinyl or azacycloalkyl-oxy, -sulphinyl or -sulphenyl group, pharmaceutical compositions comprising them